An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
Authors
Keywords
HIV-1, T cells, Diarrhea, Immune response, Face, HIV, Adjustment of dosage at steady state, Cytotoxic T cells
Journal
PLoS One
Volume 13, Issue 6, Pages e0198158
Publisher
Public Library of Science (PLoS)
Online
2018-06-08
DOI
10.1371/journal.pone.0198158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
- (2017) Cynthia L. Gay et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
- (2015) Fiona Wightman et al. AIDS
- Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma
- (2015) Ashley L. Altman et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma
- (2014) Yan Feng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection
- (2014) V. Cecchinato et al. JOURNAL OF IMMUNOLOGY
- HIV cure research: Advances and prospects
- (2014) Caroline P. Passaes et al. VIROLOGY
- Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
- (2013) Jedd D. Wolchok et al. Annals of the New York Academy of Sciences
- Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy
- (2013) Karin K. Pedersen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- Mechanism of T cell exhaustion in a chronic environment
- (2011) Hyun-Tak Jin et al. BMB Reports
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Immunologic Assays for Detecting Immune Responses in HIV Immunotherapeutic Studies: AIDS Clinical Trials Group Trial A5181
- (2010) B. J. C. Macatangay et al. Clinical and Vaccine Immunology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
- (2010) Axel Hoos et al. SEMINARS IN ONCOLOGY
- Revisiting Immune Exhaustion During HIV Infection
- (2010) Alka Khaitan et al. Current HIV/AIDS Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started